StockData
Champions Oncology, Inc. logo

Champions Oncology, Inc. (CSBR) stock

CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 9/30251% above fair value
$4.65−0.13 (-2.72%)

Close on Nov 12, 2026Market cap $64.72MP/E –Yield –

Champions Oncology gross margin

Gross margin is gross profit as a percentage of revenue.

Champions Oncology's gross margin for the twelve months ending Jul 31, 2026 was 49.8%. For fiscal 2026 it was 48.0%, against 50.1% the year before. The highest annual figure on record is 51.9% in fiscal 2022.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026Apr 30, 202648.0%−2.1
FY2025Apr 30, 202550.1%+8.8
FY2024Apr 30, 202441.4%−3.8
FY2023Apr 30, 202345.2%−6.7
FY2022Apr 30, 202251.9%+4.1
FY2021Apr 30, 202147.7%+0.7
FY2020Apr 30, 202047.1%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ2 2026Jul 31, 202650.5%+7.7
Q4 FY2026CQ1 2026Apr 30, 202650.8%+9.6
Q3 FY2026CQ4 2025Jan 31, 202646.7%−14.5
Q2 FY2026CQ3 2025Oct 31, 202551.7%+6.8
Q1 FY2026CQ2 2025Jul 31, 202542.9%−6.8
Q4 FY2025CQ1 2025Apr 30, 202541.1%−7.1
Q3 FY2025CQ4 2024Jan 31, 202561.2%+26.5
Q2 FY2025CQ3 2024Oct 31, 202444.9%+2.1
Q1 FY2025CQ2 2024Jul 31, 202449.7%+10.9
Q4 FY2024CQ1 2024Apr 30, 202448.2%+4.4
Q3 FY2024CQ4 2023Jan 31, 202434.7%−5.0
Q2 FY2024CQ3 2023Oct 31, 202342.8%−5.1
Q1 FY2024CQ2 2023Jul 31, 202338.8%−9.9
Q4 FY2023CQ1 2023Apr 30, 202343.9%−7.8
Q3 FY2023CQ4 2022Jan 31, 202339.7%−11.7
Q2 FY2023CQ3 2022Oct 31, 202247.9%−4.5
Q1 FY2023CQ2 2022Jul 31, 202248.7%−3.4
Q4 FY2022CQ1 2022Apr 30, 202251.7%+7.0
Q3 FY2022CQ4 2021Jan 31, 202251.4%−5.8
Q2 FY2022CQ3 2021Oct 31, 202152.4%+8.2
Q1 FY2022CQ2 2021Jul 31, 202152.0%+7.9
Q4 FY2021CQ1 2021Apr 30, 202144.7%+2.3
Q3 FY2021CQ4 2020Jan 31, 202157.2%+5.2
Q2 FY2021CQ3 2020Oct 31, 202044.2%−4.9
Q1 FY2021CQ2 2020Jul 31, 202044.1%−0.2
Q4 FY2020CQ1 2020Apr 30, 202042.4%−4.3
Q3 FY2020CQ4 2019Jan 31, 202052.0%+3.6
Q2 FY2020CQ3 2019Oct 31, 201949.1%−1.4
Q1 FY2020CQ2 2019Jul 31, 201944.3%−7.0
Q3 FY2019CQ4 2018Jan 31, 201946.7%−2.3
Q2 FY2019CQ3 2018Oct 31, 201848.4%+0.9
Q1 FY2019CQ2 2018Jul 31, 201850.5%–
Q3 FY2018CQ4 2017Jan 31, 201851.3%–
Q2 FY2018CQ3 2017Oct 31, 201749.0%–
Q1 FY2018CQ2 2017Jul 31, 201747.5%–

More Champions Oncology figures

See a number that looks wrong?